Cyclodextrin Based Nanoparticles for Drug Delivery and Theranostics

Area of Science:

• Pharmaceutical Sciences
• Nanotechnology
• Drug Delivery Systems

Background:

• Colloidal nanoparticulate technology is a versatile drug delivery system but faces formulation challenges.
• Cyclodextrins (CDs) are known for enhancing the solubility of poorly water-soluble drugs.
• Nanoparticles (NPs) often exhibit limitations in drug loading, stability, and targeted delivery.

Purpose of the Study:

• To explore the application of cyclodextrins (CDs) in overcoming formulation challenges associated with nanoparticulate drug delivery systems.
• To investigate how CDs can enhance the performance of nanoparticles (NPs).
• To examine the theranostic potential of CDs in conjunction with NPs.

Main Methods:

• Literature review on the use of cyclodextrins in nanoparticle formulation.
• Analysis of studies demonstrating the impact of CDs on nanoparticle properties.
• Exploration of theranostic applications enabled by CD-modified nanoparticles.

Main Results:

• CDs improve drug loading efficiency within the nanoparticle system.
• CDs enhance the stability and solubility profile of drugs encapsulated in NPs.
• CDs facilitate site-specific drug delivery, leading to improved absorption and bioavailability.
• CDs offer controlled release capabilities, enhancing safety and efficacy.
• CDs enable simultaneous diagnosis and therapeutic applications (theranostics).

Conclusions:

• Cyclodextrins effectively address inherent limitations in nanoparticulate drug delivery formulations.
• The integration of CDs with NPs significantly enhances drug loading, stability, and bioavailability.
• CD-modified nanoparticles present promising theranostic capabilities for advanced medical treatments.